116 related articles for article (PubMed ID: 21685371)
1. MicroRNA29a regulates the expression of the nuclear oncogene Ski.
Teichler S; Illmer T; Roemhild J; Ovcharenko D; Stiewe T; Neubauer A
Blood; 2011 Aug; 118(7):1899-902. PubMed ID: 21685371
[TBL] [Abstract][Full Text] [Related]
2. Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression.
Wang C; Li L; Li M; Wang W; Liu Y; Wang S
Mol Med; 2020 Nov; 26(1):114. PubMed ID: 33228517
[TBL] [Abstract][Full Text] [Related]
3. The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML.
Eyholzer M; Schmid S; Wilkens L; Mueller BU; Pabst T
Br J Cancer; 2010 Jul; 103(2):275-84. PubMed ID: 20628397
[TBL] [Abstract][Full Text] [Related]
4. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 targets the SKI gene in human melanoma cell lines.
Levati L; Pagani E; Romani S; Castiglia D; Piccinni E; Covaciu C; Caporaso P; Bondanza S; Antonetti FR; Bonmassar E; Martelli F; Alvino E; D'Atri S
Pigment Cell Melanoma Res; 2011 Jun; 24(3):538-50. PubMed ID: 21466664
[TBL] [Abstract][Full Text] [Related]
6. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia.
Zhu C; Wang Y; Kuai W; Sun X; Chen H; Hong Z
Clin Biochem; 2013 Jan; 46(1-2):49-53. PubMed ID: 22981932
[TBL] [Abstract][Full Text] [Related]
9. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
10. miR-133 regulates Evi1 expression in AML cells as a potential therapeutic target.
Yamamoto H; Lu J; Oba S; Kawamata T; Yoshimi A; Kurosaki N; Yokoyama K; Matsushita H; Kurokawa M; Tojo A; Ando K; Morishita K; Katagiri K; Kotani A
Sci Rep; 2016 Jan; 6():19204. PubMed ID: 26754824
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia.
Wang XS; Gong JN; Yu J; Wang F; Zhang XH; Yin XL; Tan ZQ; Luo ZM; Yang GH; Shen C; Zhang JW
Blood; 2012 May; 119(21):4992-5004. PubMed ID: 22493297
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-H19 inhibits apoptosis of acute myeloid leukemia cells via targeting miR-29a-3p.
Zhao TT; Liu X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):224-231. PubMed ID: 31389605
[TBL] [Abstract][Full Text] [Related]
13. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
Zhang S; Zhang Q; Shi G; Yin J
Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.
Li SM; Zhao YQ; Hao YL; Liang YY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1203-1213. PubMed ID: 30779090
[TBL] [Abstract][Full Text] [Related]
15. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
[TBL] [Abstract][Full Text] [Related]
16. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia.
Li G; Song Y; Zhang Y; Wang H; Xie J
Oncol Res; 2016; 24(2):109-16. PubMed ID: 27296951
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia.
Ritter M; Kattmann D; Teichler S; Hartmann O; Samuelsson MK; Burchert A; Bach JP; Kim TD; Berwanger B; Thiede C; Jäger R; Ehninger G; Schäfer H; Ueki N; Hayman MJ; Eilers M; Neubauer A
Leukemia; 2006 Mar; 20(3):437-43. PubMed ID: 16424870
[TBL] [Abstract][Full Text] [Related]
18. MiR-1908 promotes scar formation post-burn wound healing by suppressing Ski-mediated inflammation and fibroblast proliferation.
Xie C; Shi K; Zhang X; Zhao J; Yu J
Cell Tissue Res; 2016 Nov; 366(2):371-380. PubMed ID: 27256397
[TBL] [Abstract][Full Text] [Related]
19. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
Han YC; Park CY; Bhagat G; Zhang J; Wang Y; Fan JB; Liu M; Zou Y; Weissman IL; Gu H
J Exp Med; 2010 Mar; 207(3):475-89. PubMed ID: 20212066
[TBL] [Abstract][Full Text] [Related]
20. miR-4792 Inhibits Acute Myeloid Leukemia Cell Proliferation and Invasion and Promotes Cell Apoptosis by Targeting Kindlin-3.
Qin Y; Wang Y; Liu D
Oncol Res; 2020 Sep; 28(4):357-369. PubMed ID: 32183929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]